Correlation Between Ford and Arbutus Biopharma
Can any of the company-specific risk be diversified away by investing in both Ford and Arbutus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ford and Arbutus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ford Motor and Arbutus Biopharma Corp, you can compare the effects of market volatilities on Ford and Arbutus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ford with a short position of Arbutus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ford and Arbutus Biopharma.
Diversification Opportunities for Ford and Arbutus Biopharma
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ford and Arbutus is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Ford Motor and Arbutus Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arbutus Biopharma Corp and Ford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ford Motor are associated (or correlated) with Arbutus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arbutus Biopharma Corp has no effect on the direction of Ford i.e., Ford and Arbutus Biopharma go up and down completely randomly.
Pair Corralation between Ford and Arbutus Biopharma
Taking into account the 90-day investment horizon Ford is expected to generate 5.39 times less return on investment than Arbutus Biopharma. But when comparing it to its historical volatility, Ford Motor is 1.15 times less risky than Arbutus Biopharma. It trades about 0.02 of its potential returns per unit of risk. Arbutus Biopharma Corp is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 205.00 in Arbutus Biopharma Corp on September 4, 2024 and sell it today you would earn a total of 141.00 from holding Arbutus Biopharma Corp or generate 68.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 99.6% |
Values | Daily Returns |
Ford Motor vs. Arbutus Biopharma Corp
Performance |
Timeline |
Ford Motor |
Arbutus Biopharma Corp |
Ford and Arbutus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ford and Arbutus Biopharma
The main advantage of trading using opposite Ford and Arbutus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ford position performs unexpectedly, Arbutus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arbutus Biopharma will offset losses from the drop in Arbutus Biopharma's long position.The idea behind Ford Motor and Arbutus Biopharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Arbutus Biopharma vs. ADMA Biologics | Arbutus Biopharma vs. Adaptimmune Therapeutics Plc | Arbutus Biopharma vs. Affimed NV | Arbutus Biopharma vs. Corvus Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges |